Variables | |
---|---|
Preoperative variables | |
Age (years) | 70 (24–90) |
Gender, male | 251 (62.1%) |
Diseases, pancreatic cancer | 149 (36.9%) |
Preoperative body mass index (kg/m2) | 21.3 (14.0–35.2) |
Preoperative biliary drainage, yes | 227 (56.2%) |
Preoperative hemoglobin (g/dl) | 12.3 (7.0–16.5) |
Preoperative total protein (g/dl) | 6.9 (4.8–8.4) |
Preoperative albumin (g/dl) | 3.8 (1.7–5.0) |
Diabetes mellitus, yes | 102 (25.2%) |
Hypertension, yes | 137 (33.9%) |
Ischemic heart disease, yes | 23 (5.7%) |
Liver cirrhosis, yes | 1 (0.2%) |
Intraoperative and pathological variables | |
Operative time (min) | 428 (214–940) |
Estimated blood loss (ml) | 700 (20–4200) |
Blood transfusion, present | 116 (28.7%) |
Portal vein or superior mesenteric vein resection, yes | 80 (19.8%) |
Associated visceral resection, yes | 21 (5.2%) |
Paraaortic lymph node sampling, yes | 204 (50.5%) |
Number of lymph node harvested | 22 (0–57) |
Lymph node metastasis, yes | 180 (44.6%) |
Postoperative variables | |
White blood cell count on POD1 (/μl) | 10,395 (635–113,800) |
C-reactive protein on POD1 (mg/dl) | 9.50 (0.09–25.84) |
Drain output volume on POD1 (ml) | 266(15–1490) |
Drain amylase on POD1 (U/l) | 716 (0–95,100) |
White blood cell count on POD3 (/μl) | 8580 (730–26,230) |
C-reactive protein on POD3 (mg/dl) | 12.12 (0.87–42.32) |
Drain output volume on POD3 (ml) | 234.5 (0–1573) |
Drain amylase on POD3 (U/l) | 102.5 (3–17,200) |